Capgemini announced the signing of a new agreement with the Danish vaccine producer, AJ Vaccines, to enable its comprehensive digital transformation. As part of the agreement, Capgemini will create a new business platform that will enhance operational efficiency and agility.
With a multi-million DKK investment, AJ Vaccines is accelerating a comprehensive digital modernization of its existing SAP environment through the RISE with SAP solution, which brings together what businesses need to pursue their digital transformation to a renewable and intelligent enterprise. Capgemini was chosen for its proven track record in successfully driving strategic technology transformation initiatives in the pharma industry in Denmark.
“Our project with Capgemini is part of the ongoing digital transformation initiative of our core business function to modernize our legacy systems. Together, we are now speeding up the development of a new, cloud-based platform that will directly support our international growth strategy in Europe, Asia, and North America. With Capgemini’s expertise, we have a partner that meets our needs from strategy to implementation, with the necessary business understanding and technical skillsets to drive this transformation, along with a proven track record in SAP S/4HANA transformation,” says Ole Vahlgren, CEO at AJ Vaccines.
“Capgemini’s deep understanding of the pharmaceutical sector and extensive experience in successfully delivering large-scale SAP transformations in Denmark, will be instrumental in helping AJ Vaccines achieve its strategic business goals. I’m proud that Capgemini has been selected as the trusted business and technology transformation partner to AJ Vaccines. We are confident our tailored solutions can drive meaningful business outcomes for AJ Vaccines,” says John Fodeh, Head of Life Sciences at Capgemini Denmark.
